111 related articles for article (PubMed ID: 31908143)
21. Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.
Polverino E; Cillóniz C; Dambrava P; Gabarrús A; Ferrer M; Agustí C; Prina E; Montull B; Menendez R; Niederman MS; Torres A
Respirology; 2013 Feb; 18(2):263-71. PubMed ID: 23134361
[TBL] [Abstract][Full Text] [Related]
22. Impact of prior pulmonary tuberculosis in treatment outcomes of HCAP and CAP patients in intensive care units.
Lin FM; Feng JY; Fang WF; Wu CL; Yu CJ; Lin MC; Ku SC; Chen CW; Tu CY; Yang KY
J Microbiol Immunol Infect; 2019 Apr; 52(2):320-328. PubMed ID: 30245205
[TBL] [Abstract][Full Text] [Related]
23. [Influence of systemic corticosteroid administration in the prognosis of patients with community-acquired pneumonia].
Fernández-Herranz J; de Miguel-Díez J; Del Castillo-Rueda A; Bellón-Cano JM; Jiménez-García R; Alvarez-Sala-Walther LA
Rev Clin Esp; 2012 Jul; 212(7):337-43. PubMed ID: 22621712
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital.
Ahn JH; Lee KH; Chung JH; Shin KC; Lee CK; Kim HJ; Choi EY
Medicine (Baltimore); 2017 Oct; 96(42):e8243. PubMed ID: 29049213
[TBL] [Abstract][Full Text] [Related]
25. Comparison of clinical characteristics and outcomes between aspiration pneumonia and community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
Yamauchi Y; Yasunaga H; Matsui H; Hasegawa W; Jo T; Takami K; Fushimi K; Nagase T
BMC Pulm Med; 2015 Jul; 15():69. PubMed ID: 26152178
[TBL] [Abstract][Full Text] [Related]
26. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.
Luna CM; Palma I; Niederman MS; Membriani E; Giovini V; Wiemken TL; Peyrani P; Ramirez J
Ann Am Thorac Soc; 2016 Sep; 13(9):1519-26. PubMed ID: 27398827
[TBL] [Abstract][Full Text] [Related]
28. Factors predicting in-hospital mortality among patients admitted with community acquired pneumonia at a tertiary care hospital Karachi, Pakistan.
Iqbal N; Irfan M; Siddique F; Arshad V; Zubairi ABS
Clin Respir J; 2020 Apr; 14(4):328-334. PubMed ID: 31863551
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic treatment outcomes in community-acquired pneumonia.
Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
[TBL] [Abstract][Full Text] [Related]
30. Effects of systemic steroids in patients with severe community-acquired pneumonia.
Garcia-Vidal C; Calbo E; Pascual V; Ferrer C; Quintana S; Garau J
Eur Respir J; 2007 Nov; 30(5):951-6. PubMed ID: 17690125
[TBL] [Abstract][Full Text] [Related]
31. Impact of atypical coverage for patients with community-acquired pneumonia managed on the medical ward: results from the United States Community-Acquired Pneumonia Project.
Frei CR; Koeller JM; Burgess DS; Talbert RL; Johnsrud MT
Pharmacotherapy; 2003 Sep; 23(9):1167-74. PubMed ID: 14524648
[TBL] [Abstract][Full Text] [Related]
32. The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.
Ito A; Ito I; Inoue D; Marumo S; Ueda T; Nakagawa H; Taki M; Nakagawa A; Tatsumi S; Nishimura T; Shiota T; Ishida T
Int J Infect Dis; 2020 Mar; 92():228-233. PubMed ID: 31981766
[TBL] [Abstract][Full Text] [Related]
33. Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia.
Andersen SB; Baunbæk Egelund G; Jensen AV; Petersen PT; Rohde G; Ravn P
Infect Dis (Lond); 2017 Apr; 49(4):251-260. PubMed ID: 27887037
[TBL] [Abstract][Full Text] [Related]
34. Hospitalisation with community-acquired pneumonia among patients with type 2 diabetes: an observational population-based study in Spain from 2004 to 2013.
López-de-Andrés A; de Miguel-Díez J; Jiménez-Trujillo I; Hernández-Barrera V; de Miguel-Yanes JM; Méndez-Bailón M; Pérez-Farinós N; Salinero-Fort MÁ; Jiménez-García R
BMJ Open; 2017 Jan; 7(1):e013097. PubMed ID: 28057653
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males.
Arnold FW; Wiemken TL; Peyrani P; Mirsaeidi M; Ramirez JA;
Eur Respir J; 2013 May; 41(5):1135-40. PubMed ID: 22835618
[TBL] [Abstract][Full Text] [Related]
36. COPD is associated with increased mortality in patients with community-acquired pneumonia.
Restrepo MI; Mortensen EM; Pugh JA; Anzueto A
Eur Respir J; 2006 Aug; 28(2):346-51. PubMed ID: 16611653
[TBL] [Abstract][Full Text] [Related]
37. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
Wongsurakiat P; Chitwarakorn N
BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
[TBL] [Abstract][Full Text] [Related]
38. Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.
Liapikou A; Toumbis M; Torres A
Expert Opin Drug Saf; 2015 Aug; 14(8):1237-47. PubMed ID: 26113207
[TBL] [Abstract][Full Text] [Related]
39. Emergency department crowding is associated with 28-day mortality in community-acquired pneumonia patients.
Jo S; Kim K; Lee JH; Rhee JE; Kim YJ; Suh GJ; Jin YH
J Infect; 2012 Mar; 64(3):268-75. PubMed ID: 22227383
[TBL] [Abstract][Full Text] [Related]
40. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
